It is a fantastic result further validating the B-cell tech. On top of it, stage 3/4 patients were treated, not early stage as so many other drugs in their trials. Again, IMU's vax has outperformed current T-cell vax compared to their stages of development.
Problem is, IMU should have stated a comparison to the market leaders to get the markets attention. We can't expect the average Joe to understand the significance of the achievements so far. But there is hope, Big Pharma will have to accept the correct price tag soon.
GLTA
Media Thread, page-5619
-
- There are more pages in this discussion • 10,128 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.001(2.04%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $424.8K | 8.751M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 69 | 8622849 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 1925890 | 9 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |